据南海网报道称，吴冰是国内首例创新使用吉瑞替尼，也是首位使用博鳌研究型医院实现新药械转化，共同治疗复发性难治性FLT3突变急性髓系白血病成年患者。 海南省人民医院血液内科主任林丽娥透露，吴冰使用特许药 ...

近年来，在政策鼓励创新药发展的风口下，真正具有创新能力、提供临床价值、管线推进速度走在前列的企业正脱颖而出，值博率陡增，比如差异化创新能力持续提高，积极寻求强强联合机会的东阳光长江药业。智通财经APP了解到，11月25日盘后，东阳光长江药业(0155 ...

Daiichi Sankyo’s Vanflyta has become the first drug in the US to be approved for newly-diagnosed acute myeloid leukaemia (AML) with FLT3-ITD mutations, nearly four years after being rejected by ...

See the committee papers for full details of the evidence. For people who can have intensive chemotherapy, initial treatment for FLT3‑ITD‑positive AML is normally midostaurin with standard ...

It has been approved for the treatment of newly diagnosed (FLT3-ITD-positive) acute myeloid leukaemia on the NHS in Scotland. Acute myeloid leukaemia is a fast-growing type of blood cancer that ...